Add Formweb to your mobile device
Search results for:
alemtuzumab
alemtuzumab
Brand names: Campath, Lemtrada
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOLUTION, INTRAVENOUS | 10 mg/mL; 30 mg/mL | Restricted |
Last updated: Jul. 13, 2023
- Black Box Warning: Autoimmunity, Infusion Reactions, and Malignacies; Autoimmune Hepatitis - LEMTRADA; Cytopenias, Infusion-Related Reactions, and Infections - CAMPATH
- REMS: View FDA REMS info
- Restricted: alemtuzumab (Lemtrada) is restricted to use in the Outpatient setting and is a REMS medication
Lemtrada (alemtuzumab) FDA REMS Information
Campath (alemtuzumab) procurement via Clinigen information